Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil J Greening

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 18, 2026
Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA TrialsJadwiga A Wedzicha, Àlvar Agustí, Christopher E Brightling, et al.
Thorax|July 25, 2013
British Thoracic Society guideline on pulmonary rehabilitation in adultsCharlotte E Bolton, Elaine F Bevan-Smith, John D Blakey, et al.
Eclinicalmedicine|September 2, 2025
Impact of pulmonary rehabilitation programme design on effectiveness in COPD: a systematic review and component network meta-analysisThomas J C Ward, Lorna Latimer, Enya Daynes, et al.
NEJM Evidence|April 30, 2025
Mepolizumab for COPD with Eosinophilic Phenotype following HospitalizationCara A Flynn, Hamish J C McAuley, Omer Elneima, et al.
The European Respiratory Journal|February 16, 2023
Lung volume reduction surgery <i>versus</i> endobronchial valves: a randomised controlled trialSara C Buttery, Winston Banya, Rocco Bilancia, et al.
Thorax|June 5, 2026
Establishing the top 10 research priorities for lung volume reduction treatment for people with COPDSara C Buttery, Richard Barraclough, Timothy J P Batchelor, et al.
The Lancet. Respiratory Medicine|March 27, 2022
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trialAhmed J Yousuf, Seid Mohammed, Liesl Carr, et al.
Immunity & Ageing : I & A|January 11, 2024
Accelarated immune ageing is associated with COVID-19 disease severityJanet M Lord, Tonny Veenith, Jack Sullivan, et al.
BMJ Open|April 9, 2025
Understanding Infection, Viral Exacerbation and Respiratory Symptoms at Admission-Longitudinal (UNIVERSAL) study: a prospective observational cohort study protocolTommaso Morelli, Martha Purcell, Pedro Rodrigues, et al.
Lancet (London, England)|May 18, 2026
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trialsAlberto Papi, Neil J Greening, Surya P Bhatt, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|May 18, 2026
Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA TrialsJadwiga A Wedzicha, Àlvar Agustí, Christopher E Brightling, et al.
Thorax|July 25, 2013
British Thoracic Society guideline on pulmonary rehabilitation in adultsCharlotte E Bolton, Elaine F Bevan-Smith, John D Blakey, et al.
Eclinicalmedicine|September 2, 2025
Impact of pulmonary rehabilitation programme design on effectiveness in COPD: a systematic review and component network meta-analysisThomas J C Ward, Lorna Latimer, Enya Daynes, et al.
NEJM Evidence|April 30, 2025
Mepolizumab for COPD with Eosinophilic Phenotype following HospitalizationCara A Flynn, Hamish J C McAuley, Omer Elneima, et al.
The European Respiratory Journal|February 16, 2023
Lung volume reduction surgery <i>versus</i> endobronchial valves: a randomised controlled trialSara C Buttery, Winston Banya, Rocco Bilancia, et al.
Thorax|June 5, 2026
Establishing the top 10 research priorities for lung volume reduction treatment for people with COPDSara C Buttery, Richard Barraclough, Timothy J P Batchelor, et al.
The Lancet. Respiratory Medicine|March 27, 2022
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trialAhmed J Yousuf, Seid Mohammed, Liesl Carr, et al.
Immunity & Ageing : I & A|January 11, 2024
Accelarated immune ageing is associated with COVID-19 disease severityJanet M Lord, Tonny Veenith, Jack Sullivan, et al.
BMJ Open|April 9, 2025
Understanding Infection, Viral Exacerbation and Respiratory Symptoms at Admission-Longitudinal (UNIVERSAL) study: a prospective observational cohort study protocolTommaso Morelli, Martha Purcell, Pedro Rodrigues, et al.
Lancet (London, England)|May 18, 2026
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trialsAlberto Papi, Neil J Greening, Surya P Bhatt, et al.
Pageof 10